Societal Value of Intravitreal Injections for Retinal Vascular Diseases in the National Reimbursement Drug List in China

Vabysmo (faricimab-svoa) - Roche

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-5-2/societal-value-of-intravitreal-injections-for-retinal-vascular-diseases-in-the-national-reimbursement-drug-list-in-china

Yijia Feng, PhD 1; Luying Zhang, PhD 2; Dennis Alexander Ostwald, PhD 3; Malina Müller, BA, MA, PhD 3; Yan XIA, MBA 4; Haotian He, MBA 4; Wen Chen, PhD 2.

Nov 11, 2025